Citez comme : (2022, décembre) The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration. https://geertdevuyst.fr/publication/2007-ashton-the-cannabinoid-cb2-receptor-as-a-target-for-inflammation-dependent-neurodegeneration/
The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration
Article anglais Formé(e)
TitreThe Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent NeurodegenerationAuteur(s)Ashton, J., & Glass, M.PublicationCurrent NeuropharmacologyVolume5Édition2Année de publication2007Pages73-80DOIhttps://doi.org/10.2174/15701 ... EditeurBentham Science Publishers Ltd.Citez commeAshton, J., & Glass, M. (2007). The Cannabinoid CB2 Receptor as a Target for Inflammation‑Dependent Neurodegeneration. Current Neuropharmacology, 5(2), 73–80. https://doi.org/10.2174/157015907780866884